The Week in Review: September 8 – September 15, 2017

Friday, September 15, 2017 News Recap: President’s Report from HepCBC’s Annual General Meeting (AGM) HepCBC held its Annual General Meeting on September 12, 2017, and we are pleased to note that all the issues that we needed to address were covered.  Rosemary Plummer has stepped down as president after 2 GREAT YEARS of service, but the rest of the Board of Directors has been re-elected, and some very important changes to our Constitution and Bylaws ...

Women with HCV face low ovarian reserve, infertility, miscarriage

Women of child-bearing age with hepatitis C showed early signs of menopause, putting them at greater risk for infertility, gestational diabetes and miscarriage, according to a recently published study. Sustained virologic response positively impacted these outcomes. “We report that the relationship between HCV infection and reproductive status in women is much deeper and broader than previously thought, with profound consequences for reproductive function

How liver cancer develops

An international team of researchers headed up by UZH Professor Achim Weber from the Institute of Pathology and Molecular Pathology of the University Hospital Zurich and Mathias Heikenwälder, professor at the German Cancer Research Center in Heidelberg, Germany, has discovered a major mechanism in the development of liver cancer. One of the main players in this process is enzyme caspase-8, which assumes an important dual role. Liver cancer is the second...

The Week in Review: July 21 – July 28, 2017

Friday, July 28, 2017 News Recap WHD 2017 Victoria, BC in Pictures The weather was perfect; the organization and volunteers did great!!!!  The speakers were fabulous!! I only wish more people had shown up!!!  Big thanks to VPWAS and AVI for helping to make this important event a reality! Click on photos to see larger image in a new window! Should we be worried about hepatitis E? Hepatitis E virus infection (HEV) is the most common cause of a...

Compound Found in Plums Shown to Inhibit Hepatitis C Virus Entry

A naturally occurring compound in plums has been found to block the entry of the hepatitis C virus (HCV) into cultured liver cells. This finding could have positive implications for the development of new drugs to treat the disease, which the World Health Organizations (WHO) estimates affects over 70 million individuals around the world. The discovery was made by a team of researchers from the Indian Institute of Science in Bangalore focused on a flavon

New, cost effective saliva test that diagnoses liver disease

Hepatitis E virus (HEV) causes liver disease that infects an estimated 20 million people worldwide each year and kills more than 56,000. New York: Scientists have developed an easier, cost effective 'oral fluid' test that uses saliva to diagnose liver disease and may eventually help develop its treatment. Hepatitis E virus (HEV) causes liver disease that infects an estimated 20 million people worldwide each year and kills more than 56,000. "HEV isn'

Engineered liver tissue expands after transplant

Researchers at MIT, Rockefeller University, and Boston University have developed a new way to engineer liver tissue, by organizing tiny subunits that contain three types of cells embedded into a biodegradable tissue scaffold. Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available. To help add

Transplanting kidneys with Hepatitis C saves patients’ lives, cures disease

"Just because the donor has hepatitis C, their kidney quality may not be impaired, especially if you can cure the virus. Because the disease exerts its effects very slowly, it’s possible that a young donor or someone in the early stages of the disease may have very few health problems that result from HCV, meaning those kidneys are high-quality." More than 97,000 people in the United States are currently awaiting kidney transplants—waits that can often ta...

Researchers identify how class of drugs blocks Hepatitis C virus replication

Findings reveal a difference between strains of HCV Chapel Hill, NC - Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today. While effective combination therapies have re

On-the-spot hepatitis test being developed in Swansea

An on-the-spot test to diagnose three types of hepatitis is being developed. It would use a patient's saliva instead of blood and the test would be as simple and quick as a blood glucose sensor or a pregnancy test. Current screening for hepatitis A, B and C involves taking blood with results taking up to seven days. The two-year project is a joint venture between the UK and China with Swansea playing a key role through Swansea University's Centre fo